RECRUITINGOBSERVATIONAL
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
About This Trial
This is a non-interventional, prospective, post authorization safety study. Patients with gMG who are expected to start treatment with efgartigimod at enrolment or are within their first cycle of efgartigimod at enrolment will be eligible to enroll into the efgartigimod cohort. Patients with gMG who have not been exposed to efgartigimod and for whom it is not planned to start treatment with efgartigimod at enrolment will be eligible to enroll into the non-efgartigimod cohort.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients diagnosed with gMG who are expected to start commercial efgartigimod at enrolment or who are within their first cycle of efgartigimod at enrolment or Patients diagnosed with gMG who have not been exposed to efgartigimod and for whom it is not planned to start treatment with efgartigimod at enrolment
- Have provided appropriate written willing to sign a consent form
Who Should NOT Join This Trial:
- None
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients diagnosed with gMG who are expected to start commercial efgartigimod at enrolment or who are within their first cycle of efgartigimod at enrolment or Patients diagnosed with gMG who have not been exposed to efgartigimod and for whom it is not planned to start treatment with efgartigimod at enrolment
* Have provided appropriate written informed consent
Exclusion Criteria:
* None
Treatments Being Tested
BIOLOGICAL
efgartigimod
efgartigimod
Locations (20)
UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,
San Francisco, California, United States
SFM Clinical Research, LLC
Boca Raton, Florida, United States
University of Florida College of Medicine Jacksonville
Jacksonville Beach, Florida, United States
Medsol Clinical Research Center Inc
Port Charlotte, Florida, United States
BayCare Health System, Inc. St Anthony's Hospital
St. Petersburg, Florida, United States
Prairie Education and Research Cooperative and HSHS Medical Group
O'Fallon, Illinois, United States
University of Iowa
Iowa City, Iowa, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Norton Neuroscience Institute
Louisville, Kentucky, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
Oregon Health and Science University
Portland, Oregon, United States
University of Colorado Hospital
Portland, Oregon, United States
Medical University of South Carolina
Charleston, South Carolina, United States
National Neuromuscular Research Institute
Austin, Texas, United States
BCN Research, LLC - Gamma Therapeutic Center
Greenfield, Wisconsin, United States
Kepler Universitätsklinikum, Universitätsklinik für Neurologie, Med Campus III
Linz, Austria
UZ Leuven (University Hospitals Leuven)
Leuven, Belgium
Klinikum Altenburger Land GmbH
Altenburg, Germany